Fundraising Fox
San Francisco · Seed–Series B · 45 people tracked
Also known as ARTIS · ARTIS VENTURES MANAGEMENT, L.P.
Find your way into Artis Ventures
Sign up to see every warm intro you have to Artis Ventures
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Artis Ventures team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Investment thesis
ARTIS Ventures invests at the intersection of technology and biology, a space it refers to as 'TechBio,' backing companies that harness advances such as AI, machine learning, single-cell and multi-omics data, and computational tools to accelerate drug discovery and improve human health. The firm concentrates heavily on healthcare, life sciences, therapeutics, and biotech, while also investing in adjacent frontier technologies including fintech and consumer. It supports founders throughout their company lifecycle, providing board-level involvement and access to its network of 'Healthcare Pioneers'—senior executives from biotech, pharma, and healthcare—plus a fellowship of scientists and clinicians who help translate academic science into the clinic.
Source: firm website, verified Oct 13, 2026.
Team · 45 people
from the firm's website & curated & public directories
Director of International Marketing, joining in 2012. He previously worked at JP Morgan in Chicago serving high net worth clients and family offices, and spent 15 years overseas as CEO of a holding company with operations in manufacturing, oil services, agriculture, and consumer products.
Operating Partner who founded ARTIS portfolio company Lemonaid Health, a national direct-to-consumer telehealth provider, leading it to a $400M exit to 23andMe in 2021. An ARTIS advisor since 2021, he became Operating Partner in 2024 and serves as a board director of Eko Health.
Ruchita Sinha combines deep cellular and molecular biology training with an MBA in finance and Sanofi‑Genzyme BioVentures leadership experience to offer technical, pharma-focused guidance on company and clinical program design.
Partner focused on breakthrough technologies at the convergence of technology and biology. He previously advised institutional investors in the private secondary market and worked in software development and product management, and serves on boards including Second Front Systems and Locus Biosciences. He holds a B.A. from the University of Tennessee and FINRA Series 62, 63, 65 licenses.
Frontier technology investor focused on healthcare, fintech, and consumer. He previously incubated Spur Labs, worked at ARTIS portfolio company Quid, and was a fellow at Longitude Capital. He holds an MBA from Stanford GSB and an AB from Harvard.
Partner focused on early-stage investments in frontier technologies advancing the human condition, with physician-scientist training spanning clinical medicine, biomedical research, global health, and policy. He completed his BS at Yale and is a Paul & Daisy Soros Fellow.
Founder and Managing Partner of ARTIS, recognized on the Forbes Midas List and as a TechCrunch VC of the Year finalist. His investments include StemCentrx, YouTube, Palantir, Cohesity, and numerous life sciences companies, and he cofounded FIG (Food is Good) and Onto Health.
Partner focused on sourcing, diligencing, and supporting therapeutics companies, holding five board seats across the portfolio. A former ARTIS Fellow, he holds a PhD in Chemistry from Stanford and a BS in Chemical Engineering from UCLA.
ARTIS Fellow and PhD candidate in Electrical Engineering at Stanford in the Chichilnisky Lab, working on brain-computer interfaces for vision restoration and an NSF Graduate Research Fellowship recipient.
ARTIS Pioneer, a lawyer by training and former president and CEO of Lower Bucks Hospital, with over two decades of operations and management experience in payer and hospital systems.
MD-PhD investor focused on healthcare and life sciences companies. He trained as a physician-scientist with degrees from Stanford, an MD from Icahn School of Medicine at Mount Sinai, and radiation oncology residency at UCSF, and was formerly a professional ballet dancer.
ARTIS Fellow and Bioengineering PhD student at the University of Pennsylvania developing cancer immunotherapies, previously a life science strategy consultant at Kx Advisors, with a degree in Biological Engineering from MIT.
ARTIS Fellow and MD candidate at Weill Cornell Medicine and biomedical engineer developing minimally invasive cardiac devices. He founded the healthtech newsletter Future Human and co-led the Helix Healthcare Incubator.
ARTIS Fellow and Cardiology fellow at Johns Hopkins with an MD/MBA from Penn and Wharton, interested in the intersection of population health, health policy, and digital health innovation.
Bioengineer turned biotech operator who spent 18 years at Genentech before becoming COO and employee #2 at Altos Labs. She serves on the board of ARTIS portfolio company Eko.
ARTIS Fellow and dual MD/MBA candidate at Duke, previously a venture capital associate at the Oklahoma Life Science Fund, focused on expanding access to and affordability of care.
ARTIS Fellow and Emergency Medicine resident at Stanford Healthcare with an MD from Emory and biomedical/software engineering training from Georgia Tech, having worked as a biomedical engineer and a software engineer on ML tools at Google.
ARTIS Fellow and MD-PhD candidate at Albert Einstein College of Medicine, with research integrating genomics, proteomics, and metabolism, and prior drug discovery work at FibroGen and BioMarin.
ARTIS Pioneer, former President of MedImmune and current CEO of Immunocore, and one of few women to lead a company to IPO, emphasizing the coupling of science with strategy and vision.
ARTIS Pioneer and psychiatrist by training with expertise in regulatory compliance and FDA approvals, having brought drugs such as Abilify, Rexulti, Jynarque, and the first FDA-approved digital medicine Abilify MyCite to market at Otsuka.
ARTIS Fellow and PhD-MBA student at the National University of Singapore working on synthetic biology and DNA data storage, and former Global Chair of iGEM's entrepreneurship programme.
Physician with clinical experience across oncology, gastroenterology, vascular surgery, and emergency medicine, bringing a patient-centered lens and molecular research background to biotech investing. She earned honors in biomedical research at the University of New South Wales.
ARTIS Fellow and PhD candidate in Biomedical AI at Mount Sinai developing machine learning methods for single-cell and spatial biotechnologies, and co-founder of Nucleate NYC and Nucleate Policy.
ARTIS Pioneer and global retail executive with expertise in the supermarket industry, formerly CEO of Walmart Americas and Supervalu, currently Interim CEO of Save a Lot and an adjunct professor at the University of St. Thomas.
ARTIS Fellow, internal medicine resident at Brigham and Women's Hospital and MBA candidate at Harvard Business School, with research at the intersection of cardiology, health policy, and digital innovation, and co-founder of Aidra Health.
ARTIS Pioneer and co-founder of Luxe Brand Assets and Alma Hotel Management with 30+ years in hotel and real estate investment management. He served on the Council of the London School of Hygiene and Tropical Medicine for over 15 years.
ARTIS Pioneer providing consulting to the biopharma and healthcare investment space, drawing on a 15+ year pharma and diagnostics career including roles as GM & Chief Lunar Officer at Guardant Health and VP of Late Phase Strategy in Oncology at Pfizer.
Chief of Staff with over 10 years of event planning and guest relations experience, having previously worked at top Northern California hotels and restaurants including the Ritz-Carlton Half Moon Bay and Michelin-starred establishments.
Operating Partner with a career in pharmaceutical leadership, including President of CNS and Immunology at Janssen, Chief Commercial Officer at ACADIA Pharmaceuticals, and President and CEO of ViaCyte, which he led through its acquisition by Vertex Pharmaceuticals.
ARTIS Pioneer and bioengineering faculty member at UC San Diego working in synthetic biology and regenerative medicine, and scientific co-founder of Shape Therapeutics, Navega Therapeutics, Boundless Biosciences, and Seven Therapeutics.
ARTIS Pioneer who spent 10 years at Dr. Reddy's Laboratories, including as President of Promius Pharma, and currently serves as Chief Innovation Officer at Covis Pharma, bringing pharma and drug translation expertise.
ARTIS Pioneer and former CIO of Kaiser Permanente, with prior IT transformation leadership at CapitalOne and JPMorgan Chase. He serves on the boards of Silicon Valley Bank, Fastly, and CSAA Insurance Group and was named to the CIO Hall of Fame in 2019.
ARTIS Pioneer and CEO of Opyn. Formerly SVP of Strategy, Sales and Innovation at Walmart Health & Wellness and a 10-year veteran of Elevance Health (formerly Anthem), he brings extensive experience in growth strategy and payer relationships.
President and Head of R&D at Alector after 23 years at Genentech, focused on treatments for neurodegeneration. She holds a PhD in Pharmaceutical Chemistry from UCSF and was named one of 2018's Fiercest Women in Life Sciences.
ARTIS Pioneer, practicing rheumatologist and Head of Education at Brigham and Women's Hospital at Harvard Medical School, bringing rheumatology and autoimmune expertise.
ARTIS Pioneer, Strategic Advisor at NDA Group and Director at Pharma Executive Consulting, who ran the European Medicines Agency as Executive Director from 2001 to 2010, offering deep regulatory expertise.
ARTIS Pioneer and VP of Performance Management and Strategic Projects within HR at Pfizer, with 20+ years at Pfizer across strategy, market access, sales leadership, and analytics roles.
Zain Kassam is a physician trained in gastroenterology whose work centers on the gut microbiome, combining clinical GI, biostatistics, and engineering. He studied health sciences at McMaster, trained in medicine at Western University and in Internal Medicine and Gastroenterology at McMaster, earned an MPH in quantitative methods at Harvard's T.H. Chan School of Public Health, and completed a postdoctoral fellowship in microbiome engineering at MIT. He co-founded and served as CMO of OpenBiome and of Finch Therapeutics, and is currently CMO at Seed Health; he participates in Artis Ventures' Pioneers Program.
COO and Chief Compliance Officer with ARTIS for over 10 years. Previously COO of Fort Point Capital, Controller of Blum Capital Partners, and Corporate Finance Officer of Merritt Capital. He holds an accounting degree, is a CPA, and earned a JD from DePaul University College of Law.
Founder mafia
4 people who came through Artis Ventures went on to found or lead other companies.
What they invest in
from 68 of 85 portfolio companiesHealthtech ×33Biotech ×30Digital Health ×22AI & Machine Learning ×21Medical Devices ×21Deep Tech ×11SaaS ×9Enterprise Software ×6
HQs:United States×48United Kingdom×4Germany×1India×1
Who they back
founder profiles across 46 portfolio companiesFounding team size:solo founder×82 founders×143 founders×114+ founders×13
Where their founders studiedfrom 56 founders with education data
Harvard University ×4University of California, Berkeley ×4Massachusetts Institute of Technology ×3Stanford University Graduate School of Business ×3Dartmouth College ×2Heidelberg University ×2Indian Institute of Technology, Kharagpur ×2McGill University ×2
What their founders studiedfrom 56 founders with field-of-study data
Life Sciences ×17Engineering ×14Computer Science ×11Business & Management ×6Chemistry ×6Medicine ×4Economics ×3Mathematics & Statistics ×3
Where their founders worked beforefrom 58 founders with career history
Stanford University ×5Google ×3Adentro ×2Doblet ×2Juniper Networks ×2NeueHouse ×2TMRW Life Sciences ×2United States Marine Corps ×2
Accelerator rootsportfolio companies that came through a program
23 founders hold a PhD · 3 hold an MBA (of 59 with degree data)
Investments · 85 tracked
founders shown can be your intro pathBy year:2026 · 22025 · 32024 · 32023 · 92022 · 42021 · 52020 · 42019 · 22018 · 22017 · 22016 · 12015 · 240 dated
AbbVie develops and sells biopharmaceutical therapies across immunology, neuroscience, oncology, and aesthetics, addressing autoimmune diseases, neurologic conditions, blood cancers, and cosmetic applications through products like Skyrizi, Rinvoq, Humira, Vraylar, Imbruvica, and Botox.
BiotechNorth Chicago, US
Thomas A. Hurwich(Executive Officer)Timothy J. Richmond(Executive Officer)Henry Gosebruch(Executive Officer)inAzita Saleki-Gerhardt(Executive Officer)inMichael E. Severino(Executive Officer)William Chase(Executive Officer)
PartnerStuart Peterson· quoted
Co-investorsFounders Fund
Bloom Energy manufactures solid oxide fuel cell systems for onsite power generation at commercial, industrial, and data center facilities.
CleantechEnergyHardware
K.R. Sridhar(Founder, Chairman, and CEO)KR Sridhar, PhD(Founder, Chairman and Chief Executive Officer)K. R. Sridhar(Founder)KR Sridhar(Founder)
Co-investorsAlumni VenturesATEL VenturesConstellation Technology VenturesDag VenturesEnerdigm VenturesG Squared+11 more
Freenome develops early-stage cancer detection technology using blood tests to identify cancer in its earliest, most treatable phases.
AI & Machine LearningBiotechDigital HealthHealthtechMedical DevicesLondon, US
Riley Ennis(Founder)inCharles Roberts(Founder)inGabriel Otte(Founder)inAdam Stone(Chief Executive Officer and Director)Michael Altman(Chief Business Officer and Director)Shmuel (Sam) M. Cohn(Chief Financial Officer)
Co-investorsRA CapitalAgent CapitalAME Cloud VenturesAndreessen HorowitzAsset Management CompanyAverin Capital+15 more
Palantir builds data integration and analysis platforms — Gotham for defence and government, Foundry for commercial operations — and deploys forward engineers inside customer organisations.
Palo Alto, US
Peter Thiel(Founder)inStephen Cohen(Founder)Nathan Gettings(Founder)Joe Lonsdale(Founder)inAlexander C. Karp(Founder)Alex Karp(Founder)
Co-investors137 Ventures8VCA*AiSprouts VCAkkadian VenturesAllied Venture Partners+74 more
Affect Therapeutics operates an app-based digital treatment provider offering care for substance use disorders (alcohol, cannabis, opioid) and mental health conditions like depression and anxiety, using methods such as contingency management, CBT, medication-assisted treatment, and peer support.
Digital HealthHealthtechMental HealthNew York, US
Jeff DeFlavio(Co-founder)inKristin Muhlner(Executive Officer, Director)in
BoardKevin Ryan(Director)inJeff Rinehart(Director)in
Co-investorsCity LightAlleyCorpAcumen AmericaGaingelsKapor CapitalLifeArc Ventures+4 more
__Twitter.png)
Locus Biosciences develops engineered bacteriophage therapies for treating bacterial infections and conditions in immunology, oncology, and CNS disorders.
AI & Machine LearningBiotechDeep TechHealthtechRaleigh, US
Paul Garofolo(CEO & Co-founder)NICK TAYLOR(Executive Officer)inNick Conley(Vice President of Technology (Co-founder of EpiBiome, acquired by Locus))in
BoardGEOFFREY GLASS(Director)inDAVID JOHNSTON(Director)BARY BAILEY(Director)
Co-investorsAbstract VenturesHemisphere Ventures LLCDomain AssociatesLongitude CapitalStarlight VenturesTencent Holdings
Outpace Bio develops engineered protein technologies and cell therapies to treat solid tumors, focusing on protein design and T cell engineering to improve cancer treatment efficacy and safety.
BiotechDeep TechMedical DevicesSeattle, US
Marc Lajoie(Founder)inScott Boyken(Founder)inStanley Riddell(Co-Founder and Scientific Advisor)Aaron Foster(Executive Officer)inCharity Scripture(Executive Officer)inEric Soller(Executive Officer)in
Co-investorsRA CapitalAbstract VenturesATEL VenturesAtinum Investment Co. Ltd.Civilization Ventures Management, LlcGaingels+9 more
Valarian builds ACRA, an infrastructure platform for organizations requiring high levels of control, privacy, and compliance in their digital environments.
Cloud ComputingCybersecurityEnterprise SoftwareLondon, GB
Max Buchan(Co-founder & CEO)inJosh McLaughlin(Co-founder & COO)
Co-investorsIQ CapitalMolten VenturesNew Enterprise Associates (NEA)Scout VenturesLightbankFounders Factory+6 more
.jpeg){kind=logo}
Versa Networks provides SASE (Secure Access Service Edge) solutions that integrate security, networking, and analytics via cloud and on-premises platforms for enterprises and service providers.
Cloud ComputingCybersecurityEnterprise SoftwareSanta Clara, US
Apurva Mehta(Founder)inKumar Mehta(Founder)inJoaquin Rodriguez Torres(Director)Kelly AhujainLalit Kumar(Executive Officer)in
BoardJim Goetz(Director)
Co-investorsSequoia CapitalComcast VenturesB CapitalMayfield FundRPS VenturesAtlantic Vantage Point+2 more
Conceivable builds AURA, a robotic automation platform that automates manual IVF laboratory procedures using physical AI, aiming to increase accessibility and affordability of in-vitro fertilization treatments.
AI & Machine LearningDeep TechHealthtechMedical DevicesRoboticsNew York, US
Alan Murray(Founder & CEO)inAlejandro Chavez-Badiola(Founder & Chief Medical Officer)inJoshua Abram(Founder)in
BoardAike Ho(Director)Fred Destin(Director)
Board seatStuart Peterson· per SEC Form D
Co-investorsACME CapitalAdvance Venture PartnersFuture Positive CapitalMuse CapitalTime BioVentures
BiotechSan Francisco, US
Daniel Dornbusch(Executive Officer, Director)
BoardAshok Krishnamurthi(Director)inWilliam Carson(Director)
Board seatVasudev Bailey· per SEC Form D
Co-investorsAlumni VenturesAnzu PartnersCota CapitalGaingelsOlive Tree CapitalAdjuvant Capital+1 more
Overt Bio develops cell therapies that link genes to immune functions using genome-scale discovery platforms.
AI & Machine LearningBiotechMedical DevicesNew York, US
Dr. Legut(Co-Founder and CEO)Dr. Sanjana(Co-Founder)Mateusz Legut(Executive Officer, Director)Neville Sanjana(Co-Founder)inMat Legut(Co-Founder and CEO)in
Board seatVasudev Bailey· per SEC Form D
Co-investorsCivilization Ventures Management, LlcFusionGaingelsHAWKTAILWingAlexandria+2 more
HealthtechWest Palm Beach, US
Randy Beckham(Executive Officer)Eric R. Hanson(Executive Officer, Director)Charles Middleton(Executive Officer)Edward Hammel(Executive Officer)Michael Josephs(Executive Officer)David Saloff(Executive Officer, Director)in
Board seatStuart Peterson· per SEC Form D
Unnatural Products is a drug discovery platform company that develops synthetic macrocycles to target previously undruggable disease targets.
AI & Machine LearningBiotechDeep TechMedical DevicesSanta Cruz, US
Cameron Pye(Co-Founder & CEO)inJoshua Schwochert(Co-Founder & CSO)in
Board seatVasudev Bailey· per SEC Form D
Co-investorsAbstract VenturesAsset Management CompanyBetter Ventures Central LlcBlue Bear VenturesColorcon VenturesDroia Ventures+10 more
.png)
4D Path develops a cancer diagnostics technology that combines statistical physics with cancer biology to quantify cell cycle deregulations and tumor dynamics, generating indices that predict individual patient response to therapy.
AI & Machine LearningBiotechDigital HealthHealthtechBelmont, US
Rodrigo Navarro-Banzer(Founder)inRodrigo Jose Navarro(Executive Officer, Director)Satabhisa Mukhopadhyay(Founder, Chief Scientific Officer)inMario Pinto(Director)Tathagata Dasgupta(Founder, President & Chief Technology Officer)Jacopo Leonardi(Chief Executive Officer)in
Co-investorsVesalius Biocapital Partners
Activ Surgical develops intraoperative surgical intelligence technology for surgeons, using AR, AI, machine learning, and sensing to display physiological structures and functions not visible to the naked eye.
AI & Machine LearningHealthtechMedical DevicesBoston, US
Peter Kim(Founder)inMichael Ruehlman(Executive Officer)inTodd Usen(Executive Officer, Director)in
BoardEmily Casey(Director)Ashok Krishnamurthi(Director)inDavid Wells(Director)
Co-investorsReimagined VenturesAlumni VenturesBasecamp FundCastor VenturesCota CapitalDns Capital+8 more
Aether develops additives that blend into engineering-grade nylons to enable faster, high-throughput fused filament (FFF/FDM) 3D printing while maintaining mechanical strength and dimensional accuracy.
Advanced ManufacturingAI & Machine LearningBiotechDeep TechHardwareNew Materials
Pavle Jeremic(Founder & CEO)inJay Zaveri(Co-Founder & President)
Co-investors4DX VenturesAbstract VenturesBlue Bear VenturesBoxGroupCalm VenturesDolby Family Ventures+13 more
ALLInBio develops a precision immunology approach to identify and treat patients genetically predisposed to rapid progression of chronic inflammatory diseases.
BiotechHealthtechMedical Devices
Co-investors+ND Capital
Ark provides a customizable digital platform for venture capital and private equity firms to manage investor communications, performance reporting, and document sharing with their limited partners.
Enterprise SoftwareFintechSaaS
Bill Ward(Chief Executive Officer)
Co-investorsAcies InvestmentsAloft VCAlta PartnersAmity VenturesAsymmetric Capital PartnersAt One Ventures+21 more
Removing execution friction between modern technology companies and the U.S. national security ecosystem
Menlo Park, US
Rachel Olney(Director and Secretary)inPeter Dixon(Director and Chief Executive Officer)inWilliam Treseder(Director, Chief Financial Officer and Treasurer)in
Co-investorsEvolution VC PartnersForgePoint CapitalJ2 VenturesTau Ventures
Enterprise networking (Wi-Fi, switches, SD-WAN) with cloud-managed security for campuses & branches
Keerti Melkote(Founder)Pankaj Manglik(Founder)
Co-investorsAmplify PartnersAsset Management CompanyCervinGolub GrowthICCP Venture PartnersiGlobe Partners+12 more
Bettani produces dairy-free cheese using a proprietary plant-based protein derived from regenerative crop seeds, offering products with comparable taste, texture, and protein content to conventional dairy cheese.
CleantechFoodTechImpact & Social Good
Co-investorsManta Ray VenturesS2G InvestmentsToba CapitalGratitude Railroad
Cartography develops antibody-based cancer therapies using single-cell sequencing and computational biology to identify precise cellular targets.
AI & Machine LearningBiotechDeep TechMedical DevicesSouth San Francisco, US
Max Mumbach(Founding Scientist, Target Discovery)inJeffrey Verboon(Founding Scientist, Computational Biology)inAnsu Satpathy(Founder)Kevin Parker, PhD(Chief Executive Officer, Board Director; co-founder)Ansuman Satpathy, MD, PhD(Co-founder; Board Director)Howard Chang(Founder)in
Co-investors8VCAndreessen HorowitzCatalio Capital Management, LPFinchley Healthcare VenturesGaingelsGlobal BioAccess Fund+9 more
Climax (Bettani) develops dairy-free cheeses that match the taste, texture, melt and stretch of dairy cheese while providing 80–100% of the protein.
BiotechClimate TechFoodTech
Sandeep Patel(CEO)
Co-investorsAt One VenturesUntapped VenturesValor Equity PartnersCanaccord Genuity GroupClimate CapitalGlobal Founders Capital+6 more
Cohesity provides cyber resilience software that helps organizations identify and protect the minimal critical datasets and systems needed to restart operations after ransomware attacks or disasters.
Cloud ComputingCybersecurityData & InfrastructureEnterprise SoftwareSan Jose, US
Mohit Aron(Founder)inSanjay Poonen(CEO and President)inTIMOTHY ROBBINS(Executive Officer)inLORENZO MONTESI(Executive Officer)inROB SALMON(Executive Officer)inSanjay Poonen (CEO)(Founder)
Co-investors3Spoke CapitalAccelAdit Ventures Management, LlcBattery VenturesCisco InvestmentsCoatue Management+27 more
CURE operates a booking platform that connects pharmacies with delivery service partners to generate online orders.
B2B MarketplacesHealthtechSaaSBerlin, DE
Manuel Aberle(Founder)in
Co-investorsAbstract VenturesFJ LabsJ12 VenturesStella CapitalAccelAccomplice+23 more
Delfina provides a pregnancy support app, including a "Delfina Doula" feature, that lets pregnant people share symptoms and health data such as blood pressure with their providers between appointments.
Digital HealthFemTechHealthtechSan Francisco, US
Senan Ebrahim(Founder)inIsabel Fulcher(Director)inAli Ebrahim(Founder)Priyanka Vaidya(Founder)
BoardDafina Toncheva(Director)inJacob Yormak(Director)in
Co-investorsBoutique Venture PartnersBread And Butter Ventures, LlcMatchstick VenturesSemperVirens Venture CapitalSpringTime VenturesStory Ventures+7 more
.png)
Delix Therapeutics develops third-generation, non-hallucinogenic neuroplastogens for people with neurological conditions, using a discovery platform to identify novel compounds.
BiotechDigital HealthMedical Devices
David Olson(Founder)David Olson Nick Haft(Founder)Nick Haft(Founder)
Co-investorsBailey Venture PartnersCasa Verde CapitalDolby Family VenturesGaingelsIaso VenturesNoetic+9 more
Doctronic builds an AI system trained on peer-reviewed medical evidence to provide 24/7 medical triage and consultation, achieving 99.2% alignment with board-certified clinicians.
AI & Machine LearningDigital HealthHealthtechNew York, US
Matt Pavelle(Co-founder)inDr. Adam Oskowitz(Co-founder)inAdam Oskowitz(Founder)Adam Oskowitz Matt Pavelle(Founder)
Co-investorsAbstract VenturesLightspeed Venture PartnersPID Fund I, a series of DV Collective, LPSamsung NextSeven Stars VenturesTranspose Platform Management+6 more
Eko provides digital banking and financial services to underserved populations in India through a network of merchant business correspondents and an open API platform.
B2B MarketplacesDeveloper ToolsFintechSaaS
Abhinav(Co-founder)Abhishek(Co-founder)
Co-investorsCreation Investments Capital ManagementQuesta CapitalDigiTx Partners LLCHighland Capital PartnersLG Technology VenturesNTT Venture Capital
Eko provides AI-driven tools to generate customizable lifestyle imagery and graphics for e-commerce from a single product capture, enabling businesses to create varied assets without additional photo shoots.
AdTechAI & Machine LearningE-commerceRetail Tech
Yoni Bloch(Founder)
Co-investorsBetter Ventures Central LlcMarkerAgaeti VenturesDigiTx Partners LLCEast VenturesHighland Capital Partners+7 more
Eko develops FDA-cleared digital stethoscopes and AI-powered software that enables healthcare professionals to detect and diagnose cardiovascular disease with greater accuracy.
AI & Machine LearningDigital HealthHealthtechMedical Devices
Connor Landgraf(Co-Founder and CEO)inTyler CrouchinJason Bellet(Co-Founder and Chief Business Officer)in
Co-investorsQuesta CapitalHighland Capital PartnersBetter Ventures Central LlcCAL InnovationCalifornia Innovation FundDigiTx Partners LLC+15 more
Enklu develops Verse, a location-based attraction platform for venue, resort, and entertainment center operators to create social entertainment experiences.
GamingAlameda, US
Raymond Kallmeyer(Founder)in
Co-investorsBrincEspt Ventures LlcIrishAngelsMotivate Venture Capital
Fabric Genomics provides an AI-based platform for next-generation sequencing (NGS) analysis, interpretation, and clinical reporting for rare disease, hereditary risk, and cancer testing.
AI & Machine LearningBiotechDigital HealthHealthtechMedical DevicesOakland, US
Martin Reese(Co-Founder, President, and CEO)inMartin Reese, Ph.D.(Co-Founder, President, and CEO)Erwin Frise(Vice President of Technology and Data Science)in
Co-investorsForesite CapitalMighty CapitalRoche Venture FundCasdin Capital
Fig is an app that helps users with dietary restrictions (gluten-free, food intolerances, ingredient avoidance) discover foods and products that match their dietary needs.
ConsumerHealthtechNew York City, US
Andrew Hollar(Founder)inJake Lynch(Founder)in
Co-investorsAllerfund Ventures, LlcGaingelsPlug and Play VenturesStreamlined Ventures
AI copilot for sales teams analyzing customer interactions and optimizing revenue strategies
London, GB
Adam Liska(Co-Founder & CEO)inDevang Agrawal(Co-Founder & CTO)in
Co-investorsFJ LabsPoint72 VenturesAtlassian VenturesCreator FundDN CapitalFramework Venture Partners+1 more
Glyphic Biotechnologies develops ProSE™, a high-throughput de novo protein sequencing technology for analyzing proteomes with single-molecule sensitivity.
BiotechDeep TechBerkeley, US
Daniel Estandian(Founder)inEd Boyden(Founder)Josh Yang(Founder)inJoshua Yang(Founder)
BoardCraig Asher(Director)inJimmy Yun(Director)in
Co-investorsBlack FlagCivilization Ventures Management, LlcFoundersX VenturesGaingelsHarpoon VenturesIn-Q-Tel+11 more
Scalable, high throughput DNA sequencing platforms.
Co-investorsARCH Venture PartnersGenesys CapitalHemisphere Ventures LLCHeran PartnersSPRINGROCK VENTURESVenrock
Inceptive builds foundation models of biological systems for drug discovery, specializing in sequence-based medicines like mRNA and peptides.
AI & Machine LearningBiotechMedical DevicesPalo Alto, US
Jakob Uszkoreit(Founder)inKevin Heyries(Executive Officer)inDiana Isabel Ajuria(Executive Officer)Do Soon Kim(Executive Officer)inJakob Uszkoreit Rhiju Das(Founder)Rhiju Das(Founder)
Co-investorsAndreessen HorowitzObvious VenturesS32Section 32NVenturesNVIDIA
Lemonaid Health is a telehealth company that lets patients access medical care and treatment online from home, including services like contraceptive pill prescriptions and UTI treatment.
ConsumerDigital HealthDirect to ConsumerHealthtechSan Francisco, US
Paul Johnson(Founder)in
Co-investorsCivilization Ventures Management, LlcCorrelation VenturesDaybreak PartnerseGateway CapitalFirebolt Ventures Management Company, LlcHealth Velocity Capital+6 more
Luminate develops medical device technology to address chemotherapy side effects, particularly hair loss and peripheral neuropathy, for oncology patients and healthcare providers.
BiotechDigital HealthHealthtechMedical DevicesGalway, US
Aaron Hannon(Founder)inBarbara Oliveira(Founder)inProf. Martin O'Halloran(Co-Founder)JAMES EVERINGHAM(Executive Officer, Director)Eldad Livni(Founder)Leonid Belkind(Founder)
Co-investorsSciFoundersY Combinator8VCAlephAtlantic Bridge VenturesFaber+13 more
Metriport provides an open-source API for retrieving and exchanging clinical data.
AI & Machine LearningCloud ComputingData & InfrastructureDeveloper ToolsDigital HealthHealthtechSan Francisco, US
Dima Goncharov(Founder)inColin Elsinga(Founder)inDima Goncharov Colin Elsinga(Founder)Melissa Lieb(Recruiter)Ray Pelegrino(Founding Recruiter)Danny Lebovitz(Chief of Staff)
Co-investorsVentureSouqY CombinatorCRV (Charles River Ventures)Innovation EndeavorsMatrixMyAsiaVC+5 more
Modern Meadow develops animal-free, bio-fabricated leather alternatives using synthetic biology and material science for the fashion, interiors, and automotive industries.
BiotechCircular EconomyNew MaterialsPine Brook, US
Gabor Forgacs(Founder)inFrancoise Marga(Founder)inKaroly Jakab(Founder)inAnna Bakst(Executive Officer, Director)inRex Liu(Executive Officer)David Williamson(CEO)in
Co-investorsAstanor VenturesBreakout LabsBreakout VenturesCollaborative FundHorizons VenturesInterplay Ventures Early Stage Management Llc+7 more
Mytos builds robotic systems that automate the manufacturing of human cells, converting input stem cells into specific cell types such as neurons and heart cells over multiple weeks.
Advanced ManufacturingBiotechDeep TechHardwareHealthtechMedical DevicesRoboticsLondon, GB
Ali Afshar(CEO)inIgnacio Willats(Founder)inHenry Miskin(Developer)James Cunningham(Hardware Design Engineer)Jack Owen(Operations)Sam O'Mahony(Senior Electronics Engineer)
Co-investorsY CombinatorAcequia Capital (AceCap)Deep Science VenturesEmles Venture PartnersIQ CapitalJude Gomila+12 more
Network Bio activates biobanks through securitization and capital infusion, providing research-grade data assets and operational infrastructure for precision medicine and biomedical research.
BiotechData & InfrastructureDigital Health
Co-investorsBreyer CapitalFounders FundS32
Umesh Maheshwari(Founder)in
Co-investorsAccelGlynn Capital ManagementLightspeed Venture PartnersNotable CapitalSequoia CapitalWing
HPE subsidiary building all-flash and hybrid flash storage arrays with InfoSight predictive analytics for data centers.
Spring, US
Suresh Vasudevan(Founder)Suresh Vasudevan (CEO)(Founder)Umesh Maheshwari(Founder)Varun Mehta(Founder)
Co-investorsAmplify PartnersAsset Management CompanyiGlobe PartnersKleiner PerkinsMenlo VenturesNew Enterprise Associates (NEA)+7 more
ONI develops the Nanoimager, an automated super-resolution imaging system.
BiotechDeep TechHardwareMedical DevicesOxford, GB
Paul Scagnetti(Chief Executive Officer)in
Co-investorsAnjostARCH Venture PartnersFuture Planet CapitalOxford Technology ManagementVertical Venture PartnersAxon Ventures+6 more
ONTO Health provides personalized fertility, hormone, and longevity care for patients at various stages of reproductive health, combining evidence-based medicine with diagnostics and wellness therapies.
Digital HealthFemTechHealthtechLongevityWellness & Fitness
Dr. Roohi Jeelani(REI, OB/GYN)
Co-investorsCortado VenturesOklahoma Life ScienceRevolutionThe Council
Opyn provides a healthcare technology platform that unifies benefits, care navigation, virtual care, price transparency, provider intelligence, and service automation for health plan members, providers, and the administrative teams that support them.
AI & Machine LearningDigital HealthHealthtechSaaS
Co-investors1kxA.Capital VenturesCoinFundDragonflyDTC CapitalParadigm+2 more
Ozlo manufactures sleep wellness products including blackout sleep masks and audio devices designed to improve sleep quality through light and sound control.
ConsumerHardwareWellness & Fitness
Co-investorsLifeArc VenturesWSS
Power builds a patient-friendly platform to discover and enroll in clinical trials, serving patients seeking access to research studies and researchers seeking to improve patient recruitment.
Digital HealthHealthtech
Brandon Li(Founder)Michael Gill(Founder)
Co-investorsContraryCRV (Charles River Ventures)Kin VenturesSure VenturesTreble CapitalAnthemis Venture+4 more
Practice Fusion provides a cloud-based electronic health record (EHR) platform for medical practices, with integrated medical billing, e-prescribing, and patient engagement tools.
Digital HealthHealthtechSaaSSan Francisco, US
Ryan Howard(Executive Officer, Director)in
BoardMark Goines(Director)Beth Seidenberg(Director)inMichael Harden(Director)Cora Tellez(Director)
Co-investorsBand of AngelsCanvas VenturesLongitude CapitalWestern Technology InvestmentDeerfield Management CompanyFelicis Ventures+6 more
NetBase Quid offers an AI-powered consumer and market intelligence platform that analyzes large volumes of unstructured external data—social media, news, reviews, patents, and broadcast—to surface trends, brand sentiment, and competitive insights.
AI & Machine LearningData & InfrastructureMarketing Tech
Bob Goodson(Founder)inAnthony Lyein
Co-investorsAtomicoIn-Q-TelWestern Technology Investment
Quid is an AI-powered consumer and market intelligence platform that analyzes large volumes of unstructured external data — social media, news, reviews, patents, and broadcast — alongside clients' internal operational data to surface trends, sentiment, and competitive insights.
AI & Machine LearningData & InfrastructureMarketing Tech
Bob Goodson(Founder)
Co-investorsThomvest VenturesAntlerAtomicoTiger Global Management
Rad AI develops generative AI models and automation solutions specifically designed for radiology and healthcare workflows.
AI & Machine LearningEnterprise SoftwareHealthtechMedical DevicesSan Francisco, US
Dr. Jeff Chang(Co-founder)inDoktor Gurson(Founder)inJeff Chang(Founder)in
BoardStuart Peterson(Director)inBruce Armstrong(Director)in
Co-investorsAlpha PartnersArray Ventures Management LlcCity LightCorewell Health VenturesCrosscourt VenturesEsplanade Ventures+13 more
Range Bio (Range Biotechnologies) develops next-generation diagnostics using translational proteomics for applications in human health.
BiotechHealthtechMedical Devices
Brandon Wilson, Ph.D.(Co-founder & CEO)Brandon Wilson(Founder)inNicolo Maganzini(Founder)Tom Soh(Founder)
Co-investorsCivilization Ventures Management, LlcFifty YearsHAWKTAILPage One VenturesPear VCFour Cities+1 more
Replay develops gene therapies for patients with rare genetic diseases.
BiotechHealthtechLongevity
Lachlan MacKinnon(CEO and Founder)Adrian Woolfson(Founder)Robert Coffin(Executive Chairman)Maria Castner-Miller(General Counsel)inRenata Martin(VP & Head of Gene Therapy)inSaurabh Sharma(VP & Head of CMC)
Co-investorsGaingelsOMX VenturesSolari CapitalAxial VC
RightSite Health provides emergency medical services (EMS) support by connecting emergency room doctors with EMS crews to assess and redirect low-acuity patients, and deploys patient navigators to address underlying clinical and social needs that drive unnecessary emergency calls.
Digital HealthHealthtechSaaSSan Antonio, US
Matthew Sedgwick(Executive Officer)inMichael Boxer(Executive Officer, Director)inJames M.O. Rubin(Executive Officer, Director)
BoardRichard Lungen(Director)inGary Swart(Director)
Co-investorsHC9 VenturesVirtue Ventures
Science Corporation develops brain-computer interface and neural engineering technology to restore vision, cognition, and mobility to patients with debilitating conditions.
AI & Machine LearningBiotechDeep TechDigital HealthMedical DevicesAlameda, US
Max Hodak(Founder)inAlan Mardinly(Founder)
Co-investors885 Capitalage1Avalanche VCBeyond CapitalConversion CapitalDuke Capital Partners+15 more
Second Front delivers software solutions to government and allied democracies to accelerate access to emerging technologies.
Defense TechDeveloper ToolsGovTechSaaSArlington, US
Peter Dixon(Founder)inTyler Sweatt(Founder)inMark Butler(Founder)inNate Hughes(Founder)Patrick Ryan(Founder)
BoardAlberto Yepez(Director)
Co-investors137 VenturesAbstract VenturesBattery VenturesBoeing HorizonX VenturesBooz Allen VenturesEvolution VC Partners+7 more
Seed provides a mobile-first digital banking service aimed at small businesses, offering banking tools and customer-support resources for starting, running, and growing a company.
FintechSaaSSan Francisco, US
Brian Merritt(CEO)inRyan Hildebrand(Founder)inAra Katz(Founder)Raja Dhir(Founder)
Co-investorsMagic HourMission and MarketY CombinatorAtomicoBold Capital PartnersBoxGroup+16 more
Seed develops clinically studied probiotic and prebiotic formulations designed to support digestive health and overall wellness through proprietary delivery technology that protects beneficial bacteria through the digestive tract.
HealthtechWellness & FitnessVenice, US
Ara Katz(Executive Officer, Director)inRajat Dhir(Executive Officer, Director)Andy Bradley(Executive Officer)
Co-investorsAlumni VenturesBold Capital PartnersBoxGroupCollaborative FundColor CapitalCota Capital+16 more
Siren Biotechnology develops next-generation AAV (adeno-associated virus) platforms for gene therapy applications, including gene repair, gene transfer, and gene editing.
BiotechDigital HealthMedical DevicesSan Francisco, US
Dr. Nicole Paulk(CEO, Founder, and President)inLauren Kelly(Founder)inSharon Tetlow(Director)Brad Allen(Director)
Co-investorsAvilaCarnrite VenturesCivilization Ventures Management, LlcGaingelsHAWKTAILNZVC+4 more
Slope provides software to manage the biospecimen lifecycle in clinical trials, giving research sites, sponsors, CROs, and labs oversight of clinical sample inventory and real-time data.
Digital HealthEnterprise SoftwareHealthtechMedical DevicesSaaSMobile, US
Rust Felix(Chief Executive Officer and Co-founder)inJonathan Rust Felix(Executive Officer, Director)Michael Felix(Executive Officer, Director)
Co-investorsAlumni VenturesBasis Set VenturesBreyer CapitalDynamo VenturesEniac VenturesHigh Country Impact Fund+4 more
Enables employees to realize the full tax benefits of Health Savings Account
AbbVie is a pharmaceutical company that discovers and develops medicines, working with external innovation partners to conduct research.
BiotechHealthtech
Co-investorsCowles VenturesFountain Healthcare PartnersNew Enterprise Associates (NEA)Western Technology InvestmentFidelity InvestmentsFounders Fund
Developing a breakthrough cellular targeted particle therapy based on BNCT
Co-investorsRising Tide
Tessera Therapeutics develops Gene Writing, a genome engineering technology platform designed to make permanent alterations to the human genome for treating diseases.
BiotechDigital HealthMedical Devices
Geoff von Maltzahn(Founder)inJoseph Romanelli(CEO)Geoffrey von Maltzahn(Founder)Jacob Rubens(Founder)Noubar Afeyan(Founder)Rob Citorik(Founder)
Co-investorsFlagship PioneeringMarch Capital PartnersOMX VenturesSoftBank Vision FundSolari CapitalToba Capital+5 more
Type6 Therapeutics is a drug-discovery company developing kinase inhibitors that target the inactive OFF-state of kinases to improve selectivity and durability against cancers that evade existing therapies.
BiotechDeep TechHealthtech
Gert Kiss(Co-founder & CEO)inAlexander Bridges(Co-founder, CSO, VP Chemistry)inJeffrey Ohren(Co-founder, VP Biology)inMihail Obrocea(Head of Development)Robert Sons(Head of Operations)
Co-investorsBoxOne VenturesOMX Ventures
Transforming the lives of patients through a functional cure for Type 1 Diabetes
BiotechSan Diego, US
Brittany Bradrick(Executive Officer)Anne Sandan(Executive Officer)Elizabeth Bui(Executive Officer)Steve White(Executive Officer)Howard Foyt(Executive Officer)inKevin D'Amour(Executive Officer)in
Co-investorsATEL VenturesBain Capital Life SciencesRA CapitalSanderling VenturesThe Vertical GroupJohnson & Johnson Innovation – JJDC+1 more
YouTube is an online video-sharing platform where people can watch, upload, and share videos and build communities around their stories.
Creator EconomyMedia & EntertainmentSocialSan Bruno, US
Neal Mohanin
Co-investorsSequoia Capital
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
AffectCerebralExonics TherapeuticsFood Is Good (FIG)Onto HealthPi BioPioneersPower Life SciencesStringifyVersa Networks
Exits · 9
4 IPOs · 5 acquisitions · showing 6AbbVieNYSE: ABBVBloom EnergyNYSE: BEFreenomeNASDAQ: FRNMPalantir Technologies Inc.NASDAQ: PLTRArubaacq. by Hewlett-PackardLemonaidacq. by 23andMe
Portfolio news
latest coverage across their companies
Metriport · prnewswire.com · Sep 19, 2026
Quid · getlatka.com · Sep 5, 2026
Cohesity · en.wikipedia.org · Sep 2, 2026
OverT Bio · entrepreneur.nyu.edu · Aug 26, 2026
Valarian · siliconangle.com · Jul 14, 2026
Arkenstone Defense · finsmes.com · Jul 8, 2026
Cartography Biosciences · finsmes.com · May 7, 2026
Frequently asked questions
- How many investments has Artis Ventures made?
- Artis Ventures has 85 tracked investments, 9 of which have exited, including 5 dated in the last 24 months.
- What stage does Artis Ventures invest at?
- Artis Ventures invests at the Seed, Series A, Series B stages.
- What is Artis Ventures's typical check size?
- Artis Ventures typically writes checks of $50K – $25M.
- What sectors does Artis Ventures focus on?
- Artis Ventures focuses on AI & Machine Learning, Biotech, Consumer, Deep Tech, Digital Health, Fintech, Healthtech, Longevity, Medical Devices.
- Where is Artis Ventures located?
- Artis Ventures is headquartered in San Francisco, US.
- Does Artis Ventures lead rounds?
- Yes, Artis Ventures leads investment rounds.
- Who does Artis Ventures co-invest with?
- Artis Ventures most often shares deals with Gaingels, Wing, Abstract Ventures, among 343 tracked co-investors.
Media · Podcasts & interviews
featuring the teamVentures #25 w/ Ameena El-Bibany - Partner @ ARTIS Ventures | BIOS
BIOS · Ameena El-Bibany
Images
Co-investors · 57
New Enterprise Associates (NEA) is a venture capital firm that partners with founders across all stages of company building, investing in technology and healthcare companies.
Wing Venture Capital is an early-stage venture fund backing founders building the AI-first economy across infrastructure, enterprise, physical, domain-specific, security, and healthcare AI.
Founders Fund is a venture capital firm that backs technology companies building transformative products.
Abstract is a San Francisco-based venture capital firm managing $1.8 billion in assets, investing in seed and early-stage companies across all sectors.
Sequoia Capital is a venture capital firm that partners with founders to build technology companies.
RA Capital Management is a healthcare and planetary health investment firm that founds, funds, and scales companies using scientific diligence, multi-stage capital, and hands-on operational support.
GV (Google Ventures) is a venture capital firm that has invested in AI and machine learning since its early days, backing more than 100 AI companies across infrastructure, life sciences, and applications.
Lightspeed Venture Partners is a global venture capital firm that backs founders from Seed through Series F and beyond, emphasizing deep, immersive partnerships with the companies it invests in.
Accel is a venture capital firm that partners with exceptional teams, positioning itself as a first partner to founders globally.
This page announces that GGV Capital split into two separate firms in March 2024: Granite Asia (Singapore, covering APAC) and Notable Capital (US, based in Silicon Valley with offices in San Francisco and New York, investing in the US, Israel, Europe, and Latin America).
Kleiner Perkins is a venture capital firm that backs founders across technology and life sciences, from early stage through growth.
Cota Capital is a San Francisco-based technology investment firm that invests in private and public US-based modern enterprise technology companies, offering founders operational expertise, market insights, and an industry network.
▶45 more co-investors
S32City LightCraft VenturesFelicis VenturesFoundation CapitalBattery VenturesMayfield FundInnovation EndeavorsSierra VenturesARCH Venture PartnersHighland Capital PartnersCorrelation VenturesQuesta CapitalVertical Venture PartnersGradient VenturesACME CapitalMadrona Venture GroupCanvas VenturesPolaris PartnersWhat If VenturesKickstartThe Venture CollectiveAstanor VenturesTRANSFORMATION CAPITALPaladin Capital GroupMolten VenturesAdvance Venture PartnersTencent HoldingsMerck Global Health Innovation FundFaberPsyMed VenturesCowles VenturesLong Journey VenturesCanaan PartnersSlow VenturesPhysical IntelligenceThrive CapitalSalesforce VenturesUnusual VenturesDigital Currency GroupPolychain CapitalRadical VenturesDigitalis VenturesRecode VenturesThiel Capital
Firms observed investing alongside Artis Ventures, from public investor directories. Shared companies are the overlap with Artis Ventures's recorded portfolio.
Similar investors
GV (Google Ventures) is a venture capital firm that has invested in AI and machine learning since its early days, backing more than 100 AI companies across infrastructure, life sciences, and applications.
Khosla Ventures is a venture capital firm that backs bold, early-stage, technology-driven companies across deep tech and other sectors, providing hands-on 'venture assistance' to help founders build category-defining businesses.
JAZZ Venture Partners is a venture capital firm investing in early- and growth-stage companies at the intersection of technology, science, and human performance across enterprise, wellness, healthcare, and consumer markets.
Snatched Ventures is a San Francisco-based early-stage venture capital firm backing DeepTech startups focused on sustainable innovation and operational transformation. It is led by a two-GP team combining corporate development and institutional investment management experience.
NJF Capital is the venture investment arm of NJF Holdings, the private investment group founded by Nicole Junkermann. It invests internationally in companies building transformative technologies across life sciences, deep tech, fintech, and human performance.